You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phase III study

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Osteoporosis Trial in Seoul (PBK_L2201, Placebo)

Not yet recruiting
  • Osteoporosis
  • Seoul, Korea, Republic of
    The Catholic University of Korea Yeouido Saint Mary's Hospital
Nov 29, 2023

HR+/HER2-breast Cancer Trial (Standard endocrine therapy plus Apatinib)

Not yet recruiting
  • HR+/HER2-breast Cancer
  • Standard endocrine therapy plus Apatinib
  • (no location specified)
Jun 2, 2023

Epidermolysis Bullosa Trial (allo-APZ2-OTS, Placebo)

Not yet recruiting
  • Epidermolysis Bullosa
  • (no location specified)
Jul 18, 2022

Hepatocellular Carcinoma, Narrow Margin, Adjuvant Stereotactic Body Radiotherapy Trial in Hangzhou (stereotactic body radiation

Not yet recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • stereotactic body radiation therapy
  • regular follow-up
  • Hangzhou, Zhejiang, China
    the second affiliated hospital of Zhejiang University
Nov 3, 2022

Acute Respiratory Distress Syndrome, Ventilation Perfusion Mismatch, Respiratory Failure Trial in Istanbul (Prone Positioning)

Recruiting
  • Acute Respiratory Distress Syndrome
  • +2 more
  • Prone Positioning
  • Istanbul, Turkey
    Hamidiye Etfal Hospital
Sep 7, 2022

Benign Masseteric Hypertrophy Trial in Dongjak (Botulinum toxin type A, normal Saline)

Recruiting
  • Benign Masseteric Hypertrophy
  • Botulinum toxin type A
  • normal Saline
  • Dongjak, Seoul, Korea, Republic of
    Chung-Ang University Hospital
Jul 26, 2023

Alzheimer Trial (Tricaprilin, Placebo)

Not yet recruiting
  • Alzheimer Disease
  • (no location specified)
Mar 30, 2023

Nasopharyngeal Carcinoma, Nasopharyngeal Tumors, Nasopharyngeal Diseases Trial in Guangzhou (Nimotuzumab, Cisplatin)

Recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 3, 2022

Gastric or Esophagogastric Junction Adenocarcinoma Trial (nimotuzumab plus paclitaxel, plus paclitaxel)

Not yet recruiting
  • Gastric or Esophagogastric Junction Adenocarcinoma
  • nimotuzumab plus paclitaxel
  • placebo plus paclitaxel
  • (no location specified)
Aug 3, 2023

Cervical Cancer, Genital Wart, CIN Trial in Nanning (Zerun HPV-9, GARDASIL ®9)

Active, not recruiting
  • Cervical Cancer
  • +4 more
  • Zerun HPV-9
  • GARDASIL ®9
  • Nanning, Guangxi, China
    GuangXi Center for Diseases Control and Prevention
Oct 26, 2022

Human Papillomavirus Infection Trial in Guangzhou, Nanjing, Taiyuan (Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58)

Active, not recruiting
  • Human Papillomavirus Infection
  • Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia coli)
  • Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)（GARDASIL®）
  • Guangzhou, Guangdong, China
  • +2 more
Dec 30, 2022

Huntington Disease Trial (NestaCell®)

Not yet recruiting
  • Huntington Disease
  • NestaCell®
  • (no location specified)
Oct 18, 2023

Metastatic Breast Cancer Trial (SKB264, Eribulin, Capecitabine)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Oct 7, 2023

Breast Cancer, Triple Negative Breast Cancer Trial (Antivascular therapy, Chemotherapy)

Not yet recruiting
  • Breast Cancer
  • Triple Negative Breast Cancer
  • (no location specified)
Jun 11, 2023

COVID-19 Trial in Xi'an (Meplazumab for injection, Normal saline)

Recruiting
  • COVID-19
  • Meplazumab for injection
  • Normal saline
  • Xi'an, China
    First Affiliated Hospital of the Air Force Medical University
Apr 13, 2023

NSCLC, EGFR Activating Mutation Trial in Changsha, Shanghai (TY-9591, Osimertinib, Osimertinib)

Recruiting
  • NSCLC
  • EGFR Activating Mutation
  • Changsha, Hunan, China
  • +1 more
Dec 6, 2022

Hepatocellular Carcinoma Trial in Shanghai (AK104, )

Not yet recruiting
  • Hepatocellular Carcinoma
  • AK104
  • placebo
  • Shanghai, Shanghai, China
    Zhongshan Hospital, Fudan University
Aug 4, 2022

Chronic Migraine Trial (Dysport®, Placebo)

Not yet recruiting
  • Chronic Migraine
  • Dysport®
  • Placebo
  • (no location specified)
Sep 14, 2023

Episodic Migraine Trial (Dysport®, Placebo)

Not yet recruiting
  • Episodic Migraine
  • Dysport®
  • Placebo
  • (no location specified)
Sep 14, 2023

Metastatic Tumor Trial in Prince George, London, Montréal (radiation, drug, other, procedure)

Not yet recruiting
  • Metastatic Tumor
  • Palliative Radiotherapy
  • +9 more
  • Prince George, British Columbia, Canada
  • +2 more
Feb 6, 2023

Glabellar Frown Lines Trial (PROTOXIN)

Not yet recruiting
  • Glabellar Frown Lines
  • PROTOXIN
  • (no location specified)
Nov 8, 2023

Malaria, Malaria,Falciparum, Vector-Borne Transmission of Infection Trial in Kaoma (Attractive Targeted Sugar Bait)

Recruiting
  • Malaria
  • +2 more
  • Attractive Targeted Sugar Bait
  • Kaoma, Western Province, Zambia
    Kaoma District
Apr 18, 2022

Hypertensive Emergency Trial (QLG2071, Cleviprex®)

Not yet recruiting
  • Hypertensive Emergency
  • (no location specified)
Jun 24, 2023

Colon Cancer Trial (Neoadjuvant chemo)

Not yet recruiting
  • Colon Cancer
  • Neoadjuvant chemotherapy
  • (no location specified)
Oct 25, 2023

Fabry Disease Trial in Buenos Aires (Recombinant human alpha galactosidase A (agalsidase beta), Recombinant human

Recruiting
  • Fabry Disease
  • Recombinant human alpha galactosidase A (agalsidase beta)
  • Recombinant human alpha-galactosidase A (agalsidase beta)
  • Buenos Aires, Argentina
    Instituto de Investigaciones Clínicas Quilmes
Apr 24, 2023